Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats

doi:10.3748/wjg.v13.i16.2298

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3233)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

391

HTML

2649

Figures (1-6)

193

Sum=3233

Apr 28, 2007 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 28, 2007; 13(16): 2298-2304
Published online Apr 28, 2007. doi: 10.3748/wjg.v13.i16.2298

Full Size Figure Download Figure

Figure 5 MPO activity was measured in the pancreas 12 h after completion of the CCK-octapeptide injections and in saline-injected control (CON) mice. Data are expressed as MPO activity. aP < 0.05 vs the saline-treated group.

Citation: Seo SW, Jung WS, Piao TG, Hong SH, Yun KJ, Park RK, Shin MK, Song HJ, Park SJ. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats. World J Gastroenterol 2007; 13(16): 2298-2304
URL: https://www.wjgnet.com/1007-9327/full/v13/i16/2298.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i16.2298